SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 8.99 |
| Enterprise Value ($M) | -8.92 |
| Book Value ($M) | -27.91 |
| Book Value / Share | -0.67 |
| Price / Book | -0.32 |
| NCAV ($M) | -34.54 |
| NCAV / Share | -0.83 |
| Price / NCAV | -0.26 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.82 |
| Return on Equity (ROE) | -5.55 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.48 |
| Current Ratio | 1.48 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 23.82 |
| Assets | 30.46 |
| Liabilities | 58.37 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 19.63 |
| Operating Income | -60.18 |
| Net Income | -60.48 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -59.92 |
| Cash from Investing | -0.12 |
| Cash from Financing | 0.34 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | AbbVie Biotechnology Ltd | 4.40 | -32.51 | |
| 13D/A | HealthCap VII, L.P. | 8.20 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 31,988 | 122,954 | 26.02 | |
| 139,836 | 558,657 | 25.03 | |
| 209,293 | 378,758 | 55.26 | |
| 59,304 | 222,810 | 26.62 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BHST – BioHarvest Sciences Inc. | BTMD – biote Corp. |
| CADL – Candel Therapeutics, Inc. | CHRS – Coherus BioSciences, Inc. |
| CLSD – Clearside Biomedical, Inc. |
Financial data and stock pages provided by
Fintel.io